These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14519892)

  • 61. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.
    Blagosklonny MV
    Cell Death Dis; 2013 Dec; 4(12):e964. PubMed ID: 24336084
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.
    Wagner RJ; Martin KA; Powell RJ; Rzucidlo EM
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C119-27. PubMed ID: 20375271
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study.
    Margolis J; McDonald J; Heuser R; Klinke P; Waksman R; Virmani R; Desai N; Hilton D
    Clin Cardiol; 2007 Apr; 30(4):165-70. PubMed ID: 17443649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
    Charron T; Nili N; Strauss BH
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):41B-55B. PubMed ID: 16498512
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.
    Kuchulakanti P; Waksman R
    Drugs; 2004; 64(21):2379-88. PubMed ID: 15481997
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial).
    Rodríguez AE; Rodríguez Alemparte M; Vigo CF; Fernández Pereira C; Llauradó C; Vetcher D; Pocovi A; Ambrose J
    Heart; 2005 Nov; 91(11):1433-7. PubMed ID: 15774608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
    Rodriguez AE; Granada JF; Rodriguez-Alemparte M; Vigo CF; Delgado J; Fernandez-Pereira C; Pocovi A; Rodriguez-Granillo AM; Schulz D; Raizner AE; Palacios I; O'Neill W; Kaluza GL; Stone G;
    J Am Coll Cardiol; 2006 Apr; 47(8):1522-9. PubMed ID: 16630986
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oral rapamycin to prevent human coronary stent restenosis: a pilot study.
    Guarda E; Marchant E; Fajuri A; Martínez A; Morán S; Mendez M; Uriarte P; Valenzuela E; Lazen R
    Am Heart J; 2004 Aug; 148(2):e9. PubMed ID: 15309012
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pilot trial of oral rapamycin for recalcitrant restenosis.
    Brara PS; Moussavian M; Grise MA; Reilly JP; Fernandez M; Schatz RA; Teirstein PS
    Circulation; 2003 Apr; 107(13):1722-4. PubMed ID: 12665483
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial).
    Rodriguez AE; Alemparte MR; Vigo CF; Pereira CF; Llaurado C; Russo M; Virmani R; Ambrose JA
    J Invasive Cardiol; 2003 Oct; 15(10):581-4. PubMed ID: 14519892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.